
November 18, 2017 - By Henry Gaston
Schafer Cullen Capital Management Inc increased its stake in Novartis Ag (Adr) (NVS) by 9.16% based on its latest 2017Q2 regulatory filing with the SEC. Schafer Cullen Capital Management Inc bought 233,292 shares as the company’s stock rose 4.17% with the market. The hedge fund held 2.78M shares of the major pharmaceuticals company at the end of 2017Q2, valued at $232.10M, up from 2.55 million at the end of the previous reported quarter. Schafer Cullen Capital Management Inc who had been investing in Novartis Ag (Adr) for a number of months, seems to be bullish on the $221.86 billion market cap company. The stock increased 1.14% or $0.95 on November 17, reaching $83.98. About 1.55M shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since November 18, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.Schafer Cullen Capital Management Inc, which manages about $10.62 billion and $8.04B US Long portfolio, decreased its stake in Altria Group Inc. (NYSE:MO) by 136,012 shares to 2.03 million shares, valued at $151.19M in 2017Q2, according to the filing. It also reduced its holding in Bidvest Group Ltd (BDVSF) by 260,719 shares in the quarter, leaving it with 16,598 shares, and cut its stake in Merck & Co. Inc. (NYSE:MRK). Among 15 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 3 Sell and 7 Hold. Therefore 33% are positive. Novartis Ag had 33 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Monday, September 11 by Cowen & Co. The company was downgraded on Wednesday, March 23 by Leerink Swann. The rating was upgraded by Morgan Stanley to “Overweight” on Wednesday, July 26. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Buy” rating by Argus Research on Thursday, November 10. Goldman Sachs maintained the stock with “Neutral” rating in Thursday, March 23 report. As per Wednesday, October 28, the company rating was downgraded by Mainfirst. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Underperform” rating by Morgan Stanley on Tuesday, April 12. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Neutral” rating by JP Morgan on Wednesday, April 19. The stock of Novartis AG (ADR) (NYSE:NVS) has “Neutral” rating given on Wednesday, January 11 by Credit Suisse. The stock of Novartis AG (ADR) (NYSE:NVS) has “Buy” rating given on Wednesday, March 8 by Societe Generale.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
